Clinical trial
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in…
NCT00363142 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00363142 |
|---|---|
| Title | A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects |
| Official title | See Detailed Description. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infection, Infection, Human Immunodeficiency Virus |
| Intervention type | Drug |
| Interventions | Half-boosted Fosamprenavir, Full Boosted Fosamprenavir |
| Enrollment | 211 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Aug 15, 2006 |
| Last update posted | Nov 5, 2010 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: